変異性ヒストロジーによる腎臓細胞癌の生存期
Quynh Chi Le1, Andrea Marmiroli2, Mattia Longoni3
1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
European urology focus
|August 21, 2025
まとめ
腎臓細胞癌 (vhRCC) の変異性組織学は,生存期間を大幅に短縮し,ほとんどのサブタイプは急激に生存期間を短縮します. 骨髄性RCCは,ステージに関係なく,特に寿命に影響します.
科学分野:
- 腫瘍学
- 泌尿器科
- 流行病学について
背景:
- 腎臓細胞癌 (vhRCC) の変異性組織学は,患者の生存に対するその影響を理解する上でユニークな課題を提示しています.
- vhRCCサブタイプと一般人口の生存期間の比較結果は,ほとんど特徴づけられていない.
研究 の 目的:
- 変異性組織細胞癌 (vhRCC) と診断された患者の生存期間を分析する.
- vhRCC患者の生存率と年齢と性別を合わせた対照群を比較する.
主な方法:
- 2004年から2016年にかけての監視,疫学,最終結果 (SEER) データベースを利用して2928件のvHRC症例を特定した.
- サルコマトイド,メゼンキマ,採集管,ラブドイド,髄膜,粘膜,神経内分泌RCCなどのサブタイプが含まれています.
- カプラン・マイヤーグラフとモンテカルロシミュレーションで 総生存率を比較しました
主要な成果:
- 粘膜性RCCを除いて,ほとんどのvhRCCサブタイプは地域または転移段階にあります.
- 転移したVHRCCは,対照群と比較して-75%から-98%の生存率低下を示した (粘膜性および神経内分泌RCCを除く).
- 地域的および局所的な段階では,大部分の vhRCC 亜型において生存率の有意な低下が示され,局所的な段階におけるラブドイドおよび粘膜性RCCは顕著な例外であった.
結論:
- 変異性組織学的腎臓細胞癌 (vhRCC) のサブタイプは,一般的に,一般集団と比較して,生存期間を大幅に短縮します.
- ローカライズされたラブドイドおよび粘膜性RCCは,研究されたvhRCCサブタイプの中で生存に最も少ない影響を示した.
- 診断時の病期に関係なく,骨髄性RCCは,寿命の顕著で有意な減少を示した.
関連する概念動画
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
02:30Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
01:29Acute Kidney Injury III: Clinical Manifestations
91
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
91
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453